Guangzhou Jeeyor Medical Research

Jeeyor is a biotechnology company headquartered in Guangzhou, China, dedicated to the advancement of cell and gene therapy (CGT). The company operates as both a therapeutic developer and a specialized contract research organization (CRO), providing critical tools such as high-titer lentiviral and AAV vectors. Their service portfolio includes CRISPR/Cas9 gene-editing, mRNA synthesis, and stable cell line construction. Jeeyor's internal research focuses on developing next-generation CAR-T cell therapies for hematological malignancies and solid tumors. By integrating platform technologies with clinical research, the company aims to provide affordable and effective precision medicine solutions. The firm maintains a strong presence in the Chinese biotech ecosystem, collaborating with academic institutions and hospitals for translational research.